has been a world leading biotechnology company developing multiple sclerosis (MS) and spinal cord injury treatments (SCI).
Saints Capital | 2020 Union St., San Francisco, CA 94123 | (415) 773-2080 | eMail Us
© 2025 All Rights Reserved
© 2022 All Rights Reserved